Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular
Clinical trial NCT04141241 · COMPLETED
Trial details
- NCT number
- NCT04141241
- Sponsor
- Bota Bio Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-04
- Primary completion
- 2018-05-04
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.